SML3356
Gefarnate
≥98% (HPLC)
别名:
(4E,8E)-5,9,13-Trimethyl-4,8,12-tetradecatrienoic acid (2E)-3,7-dimethyl-2,6-octadien-1-yl ester, (E,E,E)-4,8,12-Tetradecatrienoic acid, 5,9,13-trimetyl-, 3,7-dimetyl-2,6-octadienyl ester, Geranyl farnesylacetate
登录 查看组织和合同定价。
选择规格
变更视图
关于此项目
Assay:
≥98% (HPLC)
Form:
liquid
Storage condition:
desiccated
Quality Segment
assay
≥98% (HPLC)
form
liquid
storage condition
desiccated
color
colorless to beige
storage temp.
−20°C
SMILES string
CC(C)=CCC/C(C)=C/COC(CC/C=C(CC/C=C(CCC=C(C)C)\C)\C)=O
InChI
1S/C27H44O2/c1-22(2)12-8-14-24(5)16-10-17-25(6)18-11-19-27(28)29-21-20-26(7)15-9-13-23(3)4/h12-13,16,18,20H,8-11,14-15,17,19,21H2,1-7H3/b24-16+,25-18+,26-20+
InChI key
ZPACYDRSPFRDHO-ROBAGEODSA-N
Biochem/physiol Actions
Anti-ulcer drug that stimulates gastric mucin secretion
Gefarnate is an anti-ulcer drug that stimulates gastric mucin secretion. Also gefarnate increase secretion of mucin-like glycoprotein in rabbit conjunctival tissue. It appears to be effective in animal dry-eye models. It is approved in Japan, where it is used to treat gastritis and gastric ulcer. Gefarnate is structurally similar to anti-ulcer drug teprenone (geranyl farnesylacetate), which induces expression of HSP70, HSPB8, and HSPB1.
存储类别
10 - Combustible liquids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable